Carolyn Anna Hruban, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Fragmentation | 2 | 2021 | 240 | 0.340 |
Why?
|
DNA, Neoplasm | 2 | 2020 | 1748 | 0.220 |
Why?
|
Early Detection of Cancer | 3 | 2025 | 3238 | 0.160 |
Why?
|
Fallopian Tubes | 1 | 2017 | 179 | 0.140 |
Why?
|
Genome, Human | 3 | 2021 | 4456 | 0.130 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2017 | 196 | 0.120 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2017 | 329 | 0.120 |
Why?
|
Ovarian Neoplasms | 2 | 2025 | 4919 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 1019 | 0.110 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2017 | 480 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1973 | 0.100 |
Why?
|
Pancreas | 1 | 2019 | 1700 | 0.100 |
Why?
|
Leukocytes | 1 | 2020 | 2034 | 0.100 |
Why?
|
Sequence Analysis, DNA | 2 | 2020 | 4785 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5434 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2016 | 5342 | 0.090 |
Why?
|
Lung Neoplasms | 3 | 2021 | 13594 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1483 | 0.080 |
Why?
|
Pancreatic Neoplasms | 2 | 2019 | 5443 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4363 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2016 | 2574 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1756 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4076 | 0.060 |
Why?
|
Genomics | 2 | 2015 | 5928 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9442 | 0.050 |
Why?
|
DNA Transposable Elements | 1 | 2024 | 764 | 0.040 |
Why?
|
Neoplasms | 2 | 2019 | 22389 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8664 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2017 | 2055 | 0.040 |
Why?
|
Janus Kinase 1 | 1 | 2016 | 108 | 0.030 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2021 | 454 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6982 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2017 | 371 | 0.030 |
Why?
|
Blood Cells | 1 | 2017 | 309 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2021 | 11262 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 260 | 0.030 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2015 | 331 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 368 | 0.030 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2015 | 558 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2016 | 560 | 0.030 |
Why?
|
Mutation | 4 | 2019 | 30266 | 0.030 |
Why?
|
Cohort Studies | 3 | 2019 | 41808 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4124 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4926 | 0.020 |
Why?
|
Humans | 12 | 2025 | 768970 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2059 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22296 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2016 | 9264 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 2001 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 30046 | 0.020 |
Why?
|
Preoperative Care | 1 | 2017 | 2258 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1769 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10115 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3621 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6901 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13021 | 0.020 |
Why?
|
Female | 6 | 2025 | 397515 | 0.020 |
Why?
|
Apoptosis | 1 | 2021 | 9527 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9499 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2606 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 17173 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12873 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2830 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11116 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8513 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10400 | 0.010 |
Why?
|
DNA | 1 | 2015 | 7214 | 0.010 |
Why?
|
Immunotherapy | 1 | 2016 | 4756 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13674 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 65480 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15471 | 0.010 |
Why?
|
Male | 3 | 2024 | 365203 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39394 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59739 | 0.010 |
Why?
|
Animals | 2 | 2019 | 169335 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 223737 | 0.010 |
Why?
|
Adult | 2 | 2021 | 223851 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 60131 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 89244 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13698 | 0.010 |
Why?
|
Aged | 1 | 2021 | 171786 | 0.000 |
Why?
|
Mice | 1 | 2015 | 82072 | 0.000 |
Why?
|